These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12484188)
1. Androgenic hormones and prostate cancer risk: status and prospects. Gann PH IARC Sci Publ; 2002; 156():283-8. PubMed ID: 12484188 [No Abstract] [Full Text] [Related]
2. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. Carpenter WR; Robinson WR; Godley PA J Natl Cancer Inst; 2008 Feb; 100(3):158-9. PubMed ID: 18230791 [No Abstract] [Full Text] [Related]
3. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. Platz EA; Giovannucci E J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987 [TBL] [Abstract][Full Text] [Related]
4. Circulating steroid hormones and the risk of prostate cancer. Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592 [TBL] [Abstract][Full Text] [Related]
5. Editorial comment. Sex hormones and the risk of incident prostate cancer. Thomas JA; Bañez L; Freedland SJ Urology; 2010 Nov; 76(5):1040-1. PubMed ID: 21056251 [No Abstract] [Full Text] [Related]
6. Sex steroid hormone metabolism and prostate cancer. Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991 [TBL] [Abstract][Full Text] [Related]
7. Re: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Danby FW J Natl Cancer Inst; 2008 Oct; 100(19):1412-3. PubMed ID: 18812556 [No Abstract] [Full Text] [Related]
8. The role of testosterone in the pathogenesis of prostate cancer. Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151 [TBL] [Abstract][Full Text] [Related]
9. The biochemical epidemiology of prostatic carcinoma. Rose DP Prog Clin Biol Res; 1986; 222():43-68. PubMed ID: 3097655 [No Abstract] [Full Text] [Related]
10. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730 [TBL] [Abstract][Full Text] [Related]
11. Estrogens and mechanisms of prostate cancer progression. Carruba G Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082 [TBL] [Abstract][Full Text] [Related]
13. Androgens and prostate cancer risk: a prospective study. Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541 [TBL] [Abstract][Full Text] [Related]
14. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581 [TBL] [Abstract][Full Text] [Related]
15. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer]. Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351 [No Abstract] [Full Text] [Related]
16. Prevention of hormone-related cancers: prostate cancer. Parnes HL; Thompson IM; Ford LG J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399 [TBL] [Abstract][Full Text] [Related]
17. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction. Rittmaster RS Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794 [TBL] [Abstract][Full Text] [Related]
18. [The prostate and male hormones after 50 years of age]. de Lignières B; Martin PM Ann Med Interne (Paris); 1988; 139(6):405-9. PubMed ID: 3066250 [No Abstract] [Full Text] [Related]
19. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer. Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496 [TBL] [Abstract][Full Text] [Related]
20. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate. Scarano WR; Vilamaior PS; Taboga SR Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]